Effect of farnesyltransferase inhibitor FTI-276 on established lung adenomas from A/J mice induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone

Carcinogenesis

Volumn 21, Issue 1, 2000, Pages 113-116

  Lantry, Laura E ^a   Zhang, Zhongqiu ^a   Yao, Rusheng ^a   Crist, Keith A ^a   Wang, Yian ^a   Ohkanda, Junko ^b   Hamilton, Andrew D ^b   Sebti, Said M ^c   Lubet, Ronald A ^d   You, Ming ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b YALE UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; N [[5 [(2 AMINO 3 MERCAPTOPROPYL)AMINO][1,1' BIPHENYL] 2 YL]CARBONYL]METHIONINE; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CODON; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; GENE MUTATION; LUNG ADENOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0033959438     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.1.113     Document Type: Article

References (33)

1. Gibbs, J.B. and Oliff, A. (1994) Pharmaceutical research in molecular oncology. Cell, 79, 193-198.
2. Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
3. Barbacid, M. (1987) ras genes. Annu. Rev. Biochem., 56, 779-827.
4. Khosravi-Far, R. and Der, C.J. (1994) The Ras signal transduction pathway. Cancer Metastasis Rev., 13, 67-89.
5. Forrester, K., Almoguera, C., Han, K., Grizzle, W.E. and Perucho, M. (1987) Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature, 327, 298-303.
6. Rodenhuis, S. and Slebos, R.J.C. (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res., 52, 2665s-2669s.
7. Hancock, J.F., Magee, A.I., Childs, J.E. and Marshall, C.J. (1989) All ras proteins are polyisoprenylated but only some are palmitoylated. Cell, 57, 1167-1177.
8. Casey, P.J., Solski, P.A., Der, C.J. and Buss, J.E. (1989) p21ras is modified by a farnesyl isoprenoid. Proc. Natl Acad. Sci. USA, 86, 8323-8327.
9. Stacey, D.W., Feig, L.A. and Gibbs, G.B. (1991) Dominant inhibitory ras mutants selectively inhibit the activity of either cellular or oncogenic ras. Mol. Cell. Biol., 11, 4053-4064.
10. Moores, S.L., Schaber, M.D., Mosser, S.D., Rands, E., O'Hara, M.B., Garsky, V.M., Marshall, M.S., Pompliano, D.L. and Gibbs, J.B. (1991) Sequence dependence of protein isoprenylation. J. Biol. Chem., 266, 14603-14610.
11. Kato, K., Cox, A.D., Hisaka, M.M., Graham, S.M., Buss, J.E. and Der, C.J. (1992) Isoprenoid addition to Ras protein is the critical modification for its membrane association and transforming activity. Proc. Natl Acad. Sci. USA, 89, 6403-6407.
12. Kohl, N.E., Mosser, S.D., deSolms, S.J., Giuliani, E.A., Pompliano, D.L., Graham, S.L., Smith, R.L., Scolnick, E.M., Oliff, A. and Gibbs, J.B. (1993) Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science, 260, 1934-1937.
13. Gibbs, J.B., Pompliano, D.L., Mosser, S.D., Rands, E., Lingham, R.B., Singh, S.B., Scolnick, E.M., Kohl, N.E. and Oliff, A. (1993) Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo. J. Biol. Chem., 268, 7617-7620.
14. James, G.L., Brown, M.S. and Goldstein, J.L. (1995) Assays for inhibitors of CAAX farnesyltransferase in vitro and in intact cells. Methods Enzymol., 255, 38-46.
15. Tamanoi, F. (1993) Inhibitors of Ras farnesyltransferases. Trends Biochem. Sci., 18, 349-353.
16. Vogt, A., Qian, Y., Blaskovich, M.A., Fossum, R.D., Hamilton, A.D. and Sebti, S.M. (1995) A non-peptide mimetic of Ras-CAAX: selective inhibition of farnesyltransferase and Ras processing. J. Biol. Chem., 270, 660-664.
17. Sepp-Lorenzino, L., Ma, Z., Rands, E., Kohl, N.E., Gibbs, J.B., Oliff, A. and Rosen, N. (1995) A peptidomimetic inhibitor of farnesyl:protein transferase blocks the anchorage-dependent and -independent growth of human tumor cell lines. Cancer Res., 55, 5302-5309.
18. Lerner, E.C., Qian, Y., Blaskovich, M.A., Fossum, R.D., Vogt, A., Sun, J., Cox, A.D., Der, C.J., Hamilton, A.D. and Sebti, S.M. (1995) Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cyloplasmic accumulation of inactive Ras-Raf complexes. J. Biol. Chem., 270, 26802-26806.
19. Lerner, E.C., Qian, Y., Hamilton, A.D. and Sebti, S.M. (1995) Disruption of oncogenic K-Ras4B processing and signaling by a potent geranylgeranyltransferase I inhibitor. J. Biol. Chem., 270, 26770-26773.
20. Sun, J., Qian, Y. Hamilton, A.D. and Sebti, S.M. (1995) Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-Ras mutation and p53 deletion. Cancer Res., 55, 4243-4247.
21. Sun, J., Qian, Y., Hamilton, A.D. and Sebti, S.M. (1998) Both farnesyltransferase and geranylgeranyltransferase I inhibitors are required for inhibition of oncogenic K Ras prenylation but each alone is sufficient to suppress human tumor growth in nude mouse xenografts. Oncogene, 16, 1467-1473.
22. Belinsky, S.A., Devereux, T.R., Maronpot, R.R., Stoner, G.D. and Anderson, M.W. (1989) Relationship between formation of promutagenic adducts and the activation of the K-ras protooncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res., 49, 5305-5311.
23. Singh, J., Kulkarni, N., Kelloff, G. and Reddy, B.S. (1994) Modulation of azoxymethane induced mutational activation of ras protooncogenes by chemopreventive agents in colon carcinogenesis. Carcinogenesis, 15, 1317-1323.
24. Matzinger, S.A., Chen, B., Wang, Y. Crist, K.A., Stoner, G.D., Kelloff, G.J., Lubet, R.A. and You, M. (1997) Tissue-specific expression of the K-ras allele from the A/J parent in (A/J×TSG-p53) F1 mice. Gene, 188, 261-269.
25. Tindall, K. and Stankowski, L. (1989) Molecular analysis of spontaneous mutations at the gpt locus in Chinese hamster ovary (AS52) cells. Mutat. Res., 220, 241-253.
26. Otterson, G.A., Khleif, S.N., Chen, W., Coxon, A.B. and Kaye, F.J. (1995) CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza2′deoxycytidine. Oncogene, 11, 1211-1216.
27. Herzog, C.R., Wiseman, R.W. and You, M. (1994) Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res., 54, 4007-4010.
28. Kohl, N.E., Omer, C.A., Conner, M.W. et al. (1995) Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med., 1, 792-797.
29. James, G.L., Goldstein, J.L. and Brown, M.S. (1995) Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J. Biol. Chem., 270, 6221-6226.
30. Rowell, C.A., Kowalczyk, J.J., Lewis, M.D. and Garcia, A.M. (1997) Direct demonstration of geranylgeranylation and farnesylation of Ki-Ras in vivo. J. Biol. Chem., 272, 14093-14097.
31. Lerner, E.C., Zhang, T.-T., Knowles, D.B., Qian, Y., Hamilton, A.D. and Sebti, S.M. (1997) Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and geranylgeranyltransferase I inhibitor in human tumor cell lines. Oncogene, 15, 1283-1288.
32. Zhang, F.L., Kirschmeier, P., Carr, D., James, L., Bond, R.W., Wang, L., Patton, R., Windsor, W.T., Syto, R., Zhang, R. and Bishop, W.R. (1997) Characterization of Ha-ras, N-ras, Ki-Ras4A and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I. J. Biol. Chem., 272, 10232-10239.
33. Cox, A.D. and Der, C.J. (1997) Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras? Biochim. Biophys Acta, 1333, F51-F71.